Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer.

ABSTRACT: Aerobic glycolysis is an important metabolic adaptation of cancer cells. There is growing evidence that oxidative phosphorylation is also an active metabolic pathway in many tumors, including in high grade serous ovarian cancer. Metastasized ovarian tumors use fatty acids for their energy needs. There is also evidence of ovarian cancer stem cells privileging oxidative phosphorylation (OXPHOS) for their metabolic needs. Metformin and thiazolidinediones such as rosiglitazone restrict tumor growth by inhibiting specific steps in the mitochondrial electron transport chain. These observations suggest that strategies to interfere with oxidative phosphorylation should be considered for the treatment of ovarian tumors. Here, we review the literature that supports this hypothesis and describe poten

SUBMITTER: Nayak AP 

PROVIDER: S-EPMC6162441 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature